We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Bagpuss
Totally agree with your point. Detail and impressions very much matter. Its easy to get taken in by American corporate presentation speak - much of it well rehearsed flannel and easily spearing suckers. It could very well be a harmless slip of the tongue. - but it obviously hasnt gone unnoticed. Management is generally the most important part of the company. They control the ship and we saw what happens the management slip up the other week in the Suez Canal. But its only words. Like I said this am its what they do this next year that in my opinion will pretty much decide where this company is going. I can wait
Oh we had all better sell then!
Hi @Sam16 - An interesting presentation on Investor Meet. However, it was disappointing to note that the Exec Chairman - Jay LeCoque - was unable to get the name of his company correct in his summation of concluding remarks of the future outlook referring to "Celsis International". A slip of the tongue no doubt but these details matter and impact investors' confidence in the ability of the senior management team to deliver.
Just been listening to a senior oncologist at a London hospital lamenting the lack of diagnostic services in the NHS. This is where I will be looking to SBI to see how they move to take advantage and to develop the diversity of the business rather than focus on testing (thats not to decry the value to the co. of testing) . It would im humble opinion be a very good target area for an acquisition target. Its quite an exciting opportunity and if I see them making moves along those lines I would be motivated to make a fairly substantial commitment. Until then I am mainly an observer. Thats my take for what its worth. Always like listening to that of others.
I listened in to the investors meeting. Jay mentioned that they are about to sign a deal with an airport for onsite mobile testing. When I asked about the issue Novacyt has with DHSC, Jay mentioned that SBI has excellent relationships with DHSC.
People are looking beyond covid imo. Its good that they will be benefitting for longer than originally expected but revenue from all other areas of its business has been put on the back burner and is down on the previous year which normally would be a big no no. What i think investors are wanting to see is how the business as a whole is progressing and at the moment its difficult to tell. Thats why this am I said that Healthcare diagnostics was to me an interesting element of the report as it shows positivity about business other than covid testing. Maybe people who have been here longer than me (which I assume is most) know more about the management quality. American style corporate presentations stopped impressing me years ago ( always sound like preachers trying to convert me to the Church of Whatever) . Like I say what they do with the cash and fulfill their promises re aquisitions will be key. The covid profits were pretty much a given. The path over the next year will be interesting. Just my take.
Good to see the Private Punter picking up on SBI this morning - should bring in more interest here....
Https://twitter.com/private_punter/status/1381922917630537729
"#SBI very impressive results this morning, but much more to come in full year 2021! Hoping to speak with management in the next day or two, but suffice to say they look excellent value. Hence, my picking up some shares earlier."
I cannot understand the amount of sales. Anyone have any idea
Yes, cracking results. But it has to be remembered that they are due to Covid and the creation of the Infectious Diseases Testing unit with margins of nearly 40% serving 2 main customers - DHS and Spire Health. Notwithstanding, it is most encouraging that the Exec Chair saying that the current year will see 'aggressive growth' and that the IDT unit will be expanded to cover other technologies and locations.
A bargain, I think as all the evidence is that Covid is likely to be around for quite some time - look at Brazil..........
Would have expected a bigger bounce, should be plenty more upside from here one would think....
Must be on the cards .Debt free throwing off cash on a very low PE our day will come.
Based on these results, I make out the current PE to be approximately 1. Surely some significant upside due on this one?
I believe the market cap to be £150m. No debt (£90m repaid last year), £8m in bank year end. What's not to like-am I missing something. Any guess what the pe for next years profit will be (well under 10 my guess).
Had 4 companies report this morning.
CNS.SRC.THS.SBI. lets see what today brings .
Well that blows the naesayers oot the water.And lots more to come as they target LFTs 2021 will be even better.
Nice. Apart from the obvious I like the section on on HealthCare Diagnostics - diverse, demand building and they are preparing for it - I like that.
As Ive said before it will be nice to see what they do with the cash. Nice problem to have
Nice!
Outstanding results - 19.8p adjusted EPS puts SBI on a single-digit P/E. With a rapidly growing £8.4m cash pile which will grow hugely again this year.
The outlook remains rosy:
"SourceBio is well positioned to deliver further substantial growth in revenue, earnings and cash generation in 2021"
Plus:
"It will also continue to consider potential acquisition opportunities"
Core services will of course come back nicely too this year too, so combined with the continued need for COVID testing - which today's narrative sees continuing into 2024 - this year should be a very good one.
Looks like this BB can't wait for the results. The silence is somewhat deafening.
don - no problem and not skinny or sri lankan - though not sure what that would have to do with owt any more so than if you were a fat jock. If it helps though I dont have a pair of rosy glasses either - chucked em many years ago - too expensive. Ive been at this for over 30 years and found out many years ago that a healthy dose of scepticism kept my investments healthy. There has never been a shortage of optimists - usually just after a bullish opinion from some self interested journo especially in IC or MF- with the battle cry of 'fill yer boots' from some guy who piled in the same day
Read one on Friday morning ' the mm's cant hold this back forever - here we go'. He was proved correct at around 12.30 - only it was the wrong direction - it was NCYT he was enthusing about. There was no shortage of that sort of thing on here about 230. Thing is though as they say -DYOR- and if you are correct and confident there's no need to worry about me or anyone else who has reservations (to which by the way we are entitled). So if you are confident then crack on lad and fill yer boots. GL
Novacyt’s loss could be gain for SBI. I am glad the selling of SBI shares are very limited.
Has it
Carnage over there seems its spooked some holders here. Well sell away all the cheaper for me thanks.
Lets let the results do the talking-I for one am very confident that they will be transformational for the company
Iam thinking all those that bailed recently following a newspaper tip a few months ago will regret lack of patience.Lets see but has started the leg up.